<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>ICCRAM Medioambiente, sostenibilidad y toxicología (ICCRAM-EST)</title>
<link>https://hdl.handle.net/10259/6168</link>
<description/>
<pubDate>Mon, 12 Oct 2026 15:45:00 GMT</pubDate>
<dc:date>2026-10-12T15:45:00Z</dc:date>
<item>
<title>The Role of Dynamic 3D Models in Evaluating MXenes Toxicity: A Focus on Pulmonary and Hepatic Cells</title>
<link>https://hdl.handle.net/10259/12253</link>
<description>The Role of Dynamic 3D Models in Evaluating MXenes Toxicity: A Focus on Pulmonary and Hepatic Cells
Fuente Vivas, Dalia de la; Parra de la Parra, Sandra de la; Sendra Vega, Marta; Rumbo Lorenzo, Carlos; Martel Martín, Sonia; Barros García, Rocío; Gómez Cuadrado, Laura
Background: MXenes and Graphene possess outstanding physicochemical properties. &#13;
They have strong application potential in electronics, energy storage, and &#13;
biomedicine.&#13;
Challenge: Current nanoparticle regulations present critical gaps, particularly in human &#13;
health risk assessment. There is a growing need for Safe and Sustainable by &#13;
Design (SSbD) aligned evaluation strategies.&#13;
Aim: To bridge the in vitro–in vivo gap in nanosafety research.&#13;
Approach: Advanced in vitro models, including static and dynamic 3D cellular systems, &#13;
were applied and compared to conventional 2D cultures.&#13;
Impact: These methodologies offer promising tools for improving the hazard &#13;
assessment of 2D-nanomaterials, such as MXenes.
Póster presentado en: 59th Congress of the European Societies of Toxicology (EUROTOX 2025) "Toxicology addresses society's real life risks for sustainable health and well being", 14-17 September 2025, Athens, Greece
</description>
<pubDate>Wed, 01 Jan 2025 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://hdl.handle.net/10259/12253</guid>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>PEST-PD:The Pathto Early Parkinson´s Detection Preliminary Findings from an Ongoing Longitudinal Observational Study for Prodromal Parkinson’s disease in farmers exposed to pesticides</title>
<link>https://hdl.handle.net/10259/12250</link>
<description>PEST-PD:The Pathto Early Parkinson´s Detection Preliminary Findings from an Ongoing Longitudinal Observational Study for Prodromal Parkinson’s disease in farmers exposed to pesticides
Gómez Cuadrado, Laura; García García, David; Canepa Oneto, Antonio Jesús; Lara, Daniel de; Alonso Núñez, Belén; López Marín, Sofía; Fuente Vivas, Dalia de la; Villanueva Alameda, María Isabel; Barros García, Rocío; Aparicio Martínez, Santiago; Rodríguez Diez, Juan José; López Nozal, Carlos; Ramírez Sanz, José Miguel; Gómez-Gregoris, Irene; Catón, Beatriz; Díaz Hurtado, Jorge; Calvo Simal, Sara; Trigo, Javier; Sánchez, Javier; Lisei, Darío; Olalla Gallo, Mª Ángeles; Allende del Río, Marta; Rivadeneyra Posadas, Jéssica Jannett; Begum, Bacinoglu Merve; Moda, Fabio; Cubo Delgado, Esther
PEST-PD is a multi-center project that brings together a multidisciplinary research team composed of neurologists, primary care physicians,&#13;
physicians specialized in Clinical Analysis and Nuclear Medicine, radiophysicists, biotechnologists, biologists, biostatisticians, agricultural-,&#13;
telecommunications- and health- engineers, with the aim to understand different aspects of the prevalence of preclinical and prodromal PD in&#13;
subjects exposed and not exposed to pesticides
Póster presentado en: International Congress of Parkinson’s Disease and Movement Disorders, Seoul, Korea, October 4-8, 2026
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://hdl.handle.net/10259/12250</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Toxicologial Evaluation of Pristine MXene, PolyPyrrole Functionalized MXene, and MXene-Graphene Hybrids Using Cellular and Computational Models</title>
<link>https://hdl.handle.net/10259/12245</link>
<description>Toxicologial Evaluation of Pristine MXene, PolyPyrrole Functionalized MXene, and MXene-Graphene Hybrids Using Cellular and Computational Models
Fuente Vivas, Dalia de la; Huerta Sainz, Sergio de la; Rodriguez-Vinagre, J.; Palacios Santamaría, David; Aparicio Martínez, Santiago; Gómez Cuadrado, Laura
Background: MXenes and Graphene possess outstanding physicochemical&#13;
properties (thermal stability, electrical conductivity). They have strong&#13;
application potential in biosensors, conductive ink, and EMI shielding.&#13;
Challenge: Current (nano)particle regulations present critical gaps, particularly&#13;
in human health risk assessment. There is a growing need for Safe by&#13;
Design (SbD) aligned evaluation strategies.&#13;
Aim: Implementing NAMs (in vitro and in silico) to replace animal testing and&#13;
effectively bridge the in vitro-in vivo gap in safety assessments.&#13;
Approach: Step-1 SbD was implemented via chemical hazard identification. In&#13;
vitro NAMs (static and dynamic 3D spheroids) were compared with 2D&#13;
cultures in a multi-tiered approach integrating toxicological profiles&#13;
with predictive in silico models for mechanistic cellular analysis.&#13;
Impact: Enables SbD-driven, animal-free predictive toxicology by integrating&#13;
advanced 3D NAMs with in silico mechanistic modeling.
Póster presentado a: 23 International Congress ESTIV, Maastricht, 2026, 29 june - 2 july
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://hdl.handle.net/10259/12245</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Scaffold proteins and cytoskeletal dynamics as modulators of Ras-ERK pathway in cancer</title>
<link>https://hdl.handle.net/10259/12244</link>
<description>Scaffold proteins and cytoskeletal dynamics as modulators of Ras-ERK pathway in cancer
Fuente Vivas, Dalia de la; Casar, Berta; Crespo, Pedro
An overwhelming body of data unquestionably links the Ras-ERK&#13;
pathway to the upbringing and progression of human malignancies.&#13;
About 40% of human cancers harbor activating mutations in proteins&#13;
involved in this signaling cascade, in particular Ras and Braf. In addition&#13;
to the main proteins of this signaling pathway, there are several&#13;
regulatory proteins known as scaffold proteins, that modulate the&#13;
intensity, amplitude and duration of ERK signals. Interestingly, it can&#13;
propose the scaffold proteins as antitumoral targets. Considering the&#13;
hypothesis that scaffold proteins interact and regulate the signal&#13;
transduction through the Ras-ERK pathway in a coordinated manner&#13;
we try to find out how these interactions are regulated. Ras proteins&#13;
are distributed in different types of plasma membrane: microdomains&#13;
and endomembranes. We have previously demonstrated that&#13;
compartmentalization dictates Ras utilization of effectors, the intensity&#13;
of its signals and the biological response of the cells. Cell migration is&#13;
critical for many physiological processes and is often misregulated in&#13;
developmental disorders and pathological conditions including cancer.&#13;
MAPK signaling are known regulators of cytoskeletal dynamics during&#13;
cellular processes such as cell adhesion and migration. Our hypothesis&#13;
is that localized ERK signaling mediated through recently identified&#13;
scaffold proteins and its interactions with the cytoskeleton may&#13;
regulate specific cellular responses. Here we propose that associations&#13;
among different scaffold proteins and cytoskeleton will add one further&#13;
degree of regulation for an already tightly regulated cascade and could&#13;
provide a novel means for manipulating ERK signals, even with&#13;
therapeutic purposes.
Póster presentado en: 41 Congreso de la SEBBM, Santander, 10-13 septiembre 2018
</description>
<pubDate>Mon, 01 Jan 2018 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://hdl.handle.net/10259/12244</guid>
<dc:date>2018-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
